Skip to main content
Sequana Medical N.V. logo

Sequana Medical N.V. — Investor Relations & Filings

Ticker · SEQUA ISIN · BE0974340722 LEI · 8755009AN12Y4PEOII07 BR Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2024-04-03 Declaration of Voting R…
Country BE Belgium
Listing BR SEQUA

About Sequana Medical N.V.

https://www.sequanamedical.com/

Sequana Medical N.V. is a commercial-stage medical device company focused on developing treatments for drug-resistant fluid overload, a frequent complication in patients with liver disease, heart failure, and cancer. The company's primary product is the alfapump®, a fully implanted, wirelessly charged system that automatically and continuously removes ascites (fluid accumulation in the abdomen) into the bladder for natural elimination. It is the first U.S. FDA-approved active implantable medical device for treating recurrent or refractory ascites due to liver cirrhosis, designed to reduce or eliminate the need for therapeutic paracentesis. Sequana Medical is also advancing its DSR® (Direct Sodium Removal) therapy platform, a novel approach for managing fluid overload in heart failure patients.

Recent filings

Filing Released Lang Actions
Press release_Transparency Notification_3 April 2024_NL_vF.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Transparantiekennisgevingen van Aandeelhouders" (Shareholder Transparency Notifications) and explicitly states that the company received notifications from shareholders regarding changes in their voting rights percentages following a private placement. The content details specific shareholders (Adrianus van Herk, ParticipatieMaatschappij Vlaanderen NV) and the resulting change in their holdings relative to the total outstanding shares (crossing or falling below the 3% threshold). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant ownership levels crossing regulatory thresholds. The Belgian legal reference (Article 14 of the law of May 2, 2007) confirms this is a mandatory disclosure regarding major shareholdings. Therefore, the appropriate code is MRQ.
2024-04-03 Dutch
Press Release_FYR 2023_28 March 2024_ENG_vF.pdf
Earnings Release Classification · 95% confidence The document is an official announcement from Sequana Medical regarding its 2023 full-year financial results. It includes key highlights, business updates, outlook for 2024, and a detailed financial review with comparative tables (FY 2023 vs FY 2022). While it contains financial data, it is structured as an initial announcement of results rather than a full statutory Annual Report (10-K). It fits the definition of an Earnings Release (ER) as it provides the initial summary of financial performance and business highlights for the period. FY 2023
2024-03-28 English
Press Release_FYR 2023_28 March 2024_NL_vF.pdf
Annual Report Classification · 95% confidence The document is a comprehensive financial report for Sequana Medical NV, detailing the full-year 2023 financial results, including a consolidated profit and loss statement, operational highlights, and management outlook for 2024. It contains substantive financial data and analysis rather than being a mere announcement or certification. As it covers the full fiscal year 2023, it functions as an annual financial report. FY 2023
2024-03-28 Dutch
Project Stars -- Closing PR (ENG).pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES" and details the increase in share capital and the total number of issued shares following a private placement. It explicitly mentions the change in share capital from EUR 2,926,295.90 to EUR 3,720,562.60 and the issuance of 7,666,667 new shares. It also discusses outstanding subscription rights, options, and warrants that entitle holders to new shares. This content directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (Code: SHA). The document is a formal announcement, not a short notice of publication (RPA/RNS), and it is not a general earnings release (ER) or a full annual report (10-K).
2024-03-26 English
Project Stars -- Closing PR (NL).pdf
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated March 26, 2024, titled with an announcement regarding capital and share count updates ("SEQUANA MEDICAL KONDIGT NIEUW BEDRAG VAN KAPITAAL EN NIEUW AANTAL AANDELEN AAN"). It explicitly details the increase in share capital and the total number of issued and outstanding shares following a private placement completed on March 20/21, 2024. It also details the potential shares issuable upon exercise of various options and warrants. This content directly relates to changes in the company's capital structure and share issuance. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns a specific corporate action related to equity.
2024-03-26 Dutch
Project Stars -- Pricing PR (ENG) (FINAL).pdf
Share Issue/Capital Change Classification · 99% confidence The document is explicitly titled as a "PRESS RELEASE REGULATED INFORMATION – INSIDE INFORMATION" and announces that the company "SUCCESSFULLY RAISES EUR 11.5 MILLION IN AN EQUITY PLACEMENT." This involves the issuance of new shares via a private placement/accelerated bookbuild offering, which directly relates to fundraising and capital structure changes. The text details the number of shares issued, the issue price, the use of proceeds, and the mandatory conversion of a convertible loan based on this equity financing event. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses purely on the financing transaction.
2024-03-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.